Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Divestments (2017 - 2024)

Haemonetics (HAE) has 5 years of Divestments data on record, last reported at $1.5 million in Q1 2024.

  • For Q1 2024, Divestments changed N/A year-over-year to $1.5 million; the TTM value through Mar 2024 reached $1.5 million, down 85.9%, while the annual FY2025 figure was $43.3 million, 2786.07% up from the prior year.
  • Divestments reached $1.5 million in Q1 2024 per HAE's latest filing, down from $10.6 million in the prior quarter.
  • Across five years, Divestments topped out at $45.0 million in Q3 2020 and bottomed at -$391000.0 in Q4 2020.
  • Average Divestments over 3 years is $14.2 million, with a median of $6.1 million recorded in 2022.
  • The widest YoY moves for Divestments: up 2821.74% in 2022, down 2821.74% in 2022.
  • A 3-year view of Divestments shows it stood at -$391000.0 in 2020, then skyrocketed by 2821.74% to $10.6 million in 2022, then tumbled by 85.9% to $1.5 million in 2024.
  • Per Business Quant database, its latest 3 readings for Divestments were $1.5 million in Q1 2024, $10.6 million in Q1 2022, and -$391000.0 in Q4 2020.